Thermo Fisher Scientific
Headquartered in Waltham, Massachusetts, Thermo Fisher Scientific is a member of the Fortune 250 operating in the Pharmaceuticals Biotechnology and Life Sciences industry. Marc N. Casper serves as CEO/President and Chairman, leading the company’s C-suite executive team and the board of directors. Amongst these teams, the collective leadership is responsible for $828,907 to Republican causes and $420,611 to Democratic causes. Under their tenure, Thermo Fisher Scientific currently holds a ‘High’ rating.
Company Leadership
Marc N. Casper
Marc N. Casper currently serves as the Chairman, President, and CEO of Thermo Fisher Scientific, based in Waltham, MA, with a tenure of 22 years with the company. Casper serves on the Board of Directors at Synopsys Inc. and Previously at U.S. Bancorp. Prior to joining Thermo Fisher Scientific, Casper served in various executive leadership roles at Kendro Laboratory Products and Dade Behring.
He holds a Bachelor’s degree in economics from Wesleyan University and an M.B.A. from Harvard Business School. Casper is actively involved in various non-profit organizations, including Business Roundtable, Wesleyan University, Mass General Brigham, and the U.S.-China Business Council.
He has made political contributions, with $235,400 to the Republican party and $22,250 to the Democrat party.
Political Contributions of Leadership
Leadership
Chairman, President, & CEO
Marc N. Casper
CEO – Beauty, Executive Sponsor, Corporate Sustainability
R. Alexandra Keith
Sr. VP and President, Customer Channels
Frederick M. Lowery
VP and Chief Strategy Officer
Aditya Joshi
Chief Medical Officer
Alan Sachs
Sr. VP and President, Analytical Instruments Group
Daniel P. Shine
Sr. VP and President BioProduction
Daniella Cramp
Exec VP
Gianluca Pettiti
VP, Financial Operations
Jim Meyer
Sr. VP and President, Specialty Diagnostics
John Sos
Chief Scientific Officer
Karen E. Nelson
Sr. VP, Global Business Services
Konrad Bauer
Sr. VP and Chief HR Officer
Lisa P. Britt
Sr. VP and President, Genetic Sciences
Mark Smedley
Sr. VP and General Counsel
Michael A. Boxer
Sr. VP and President, Life Sciences and Laboratory Products
Monica Manotas
Sr. VP, Strategy and Corporate Development
Paul Parker
Sr. VP and CIO
Ryan Snyder
VP and Chief Communications Officer
Sandy Pound
SVP, & Pres. of Clinical Research
Sebastian Pacios
Sr. VP and CFO
Stephen Williamson
Exec VP and COO
Michel Lagarde
Sr. VP and President, Pharma Services
Mike Shafer
Board Member
Tyler Jacks, Ph.D.
Board Member
C. Martin Harris, MD
Director, Board Member
Debora L. Spar
Board Member
James C. Mullen
Board Member
Lars R. Sorensen
Board Member
Scott M. Sperling
Board Member
Nelson J. Chai